Literature DB >> 17055276

Cell-mediated immunity and the challenges for vaccine development.

Rosangela Salerno-Gonçalves1, Marcelo B Sztein.   

Abstract

One of the hallmarks of successful vaccination is the induction of strong and persistent memory T cell responses, a process that involves striking changes in the number and functional properties of T cells. Many questions pertaining to this complex, multifaceted process remain unanswered. Some of the key issues and challenges to optimize memory T cell responses and foster vaccine development include the optimization of effector T cell burst sizes, the use of adjuvants, cytokines and co-stimulatory molecules, epitope enhancement and the standardization of techniques to detect specific T cells. Age also has an impact on vaccine design because of the physiological changes in cell-mediated immunity that occur throughout life.

Mesh:

Substances:

Year:  2006        PMID: 17055276     DOI: 10.1016/j.tim.2006.10.004

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  28 in total

1.  Encapsulating immunostimulatory CpG oligonucleotides in listeriolysin O-liposomes promotes a Th1-type response and CTL activity.

Authors:  Chasity D Andrews; Myung-Sook Huh; Kathryn Patton; Debbie Higgins; Gary Van Nest; Gary Ott; Kyung-Dall Lee
Journal:  Mol Pharm       Date:  2012-04-06       Impact factor: 4.939

2.  Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge.

Authors:  Lei Deng; Jong R Kim; Timothy Z Chang; Han Zhang; Teena Mohan; Julie A Champion; Bao-Zhong Wang
Journal:  Virology       Date:  2017-06-13       Impact factor: 3.616

3.  Constitutive activation of Wnt signaling favors generation of memory CD8 T cells.

Authors:  Dong-Mei Zhao; Shuyang Yu; Xinyuan Zhou; Jodie S Haring; Werner Held; Vladimir P Badovinac; John T Harty; Hai-Hui Xue
Journal:  J Immunol       Date:  2009-12-21       Impact factor: 5.422

4.  Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans.

Authors:  Rezwanul Wahid; Raphael Simon; Shah J Zafar; Myron M Levine; Marcelo B Sztein
Journal:  Clin Vaccine Immunol       Date:  2012-04-04

5.  Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B.

Authors:  Rezwanul Wahid; Shah J Zafar; Monica A McArthur; Marcela F Pasetti; Myron M Levine; Marcelo B Sztein
Journal:  Clin Vaccine Immunol       Date:  2014-01-15

6.  Use of whole-blood samples in in-house bulk and single-cell antigen-specific gamma interferon assays for surveillance of Mycobacterium tuberculosis infections.

Authors:  Raffaella Palazzo; Fabiana Spensieri; Marco Massari; Giorgio Fedele; Loredana Frasca; Stefania Carrara; Delia Goletti; Clara M Ausiello
Journal:  Clin Vaccine Immunol       Date:  2007-11-21

7.  Immunological dysfunction in HIV-1-infected individuals caused by impairment of adenosine deaminase-induced costimulation of T-cell activation.

Authors:  José M Martinez-Navio; Núria Climent; Rodrigo Pacheco; Felipe Garcia; Montserrat Plana; Meritxell Nomdedeu; Harold Oliva; Cristina Rovira; Laia Miralles; José M Gatell; Teresa Gallart; Josefa Mallol; Carme Lluis; Rafael Franco
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

8.  Generation of heterogeneous memory T cells by live attenuated tularemia vaccine in humans.

Authors:  Rosangela Salerno-Gonçalves; Matthew J Hepburn; Sina Bavari; Marcelo B Sztein
Journal:  Vaccine       Date:  2009-09-30       Impact factor: 3.641

9.  Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice.

Authors:  Tao Meng; Jimmy Kwang
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

10.  Coadministration of the fungal immunomodulatory protein FIP-Fve and a tumour-associated antigen enhanced antitumour immunity.

Authors:  Ying Ding; See Voon Seow; Chiung Hui Huang; Lee Mei Liew; Yaw Chyn Lim; I Chun Kuo; Kaw Yan Chua
Journal:  Immunology       Date:  2009-03-26       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.